Manuel González-Moya

Manuel González-Moya

Auto-generated profile, based on publicly available information

Manuel González-Moya

Department of Medical Oncology. Hospital QuironSalud, Seville, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2022 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
BOBerta Obispo
Berta Obispo
PCPATRICIA CRUZ CASTELLANOS
PATRICIA CRUZ CASTELLANOS
PFPaula Jimenez Fonseca
Paula Jimenez Fonseca
JRJacobo Rogado
Jacobo Rogado
RHRaquel Hernandez
Raquel Hernandez
CCCaterina Calderon
Caterina Calderon

29 May 2023 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
PDF file
ARAdán Rodríguez-Gonzalez
Adán Rodríguez-Gonzalez
ABAlberto Carmona Bayonas
Alberto Carmona Bayonas
RGRaquel Hernandez San Gil
Raquel Hernandez San Gil
PCPATRICIA CRUZ CASTELLANOS
PATRICIA CRUZ CASTELLANOS
MAMónica Antoñanzas-Basa
Mónica Antoñanzas-Basa
CCCaterina Calderon
Caterina Calderon

3 May 2022 in Cancer Investigation
Verified
Journal Article
Closed access
VVVeronica Velasco-Durantez
Veronica Velasco-Durantez
PFPaula Jimenez Fonseca
Paula Jimenez Fonseca
CMCarla Maria Martin-Abreu
Carla Maria Martin-Abreu
IGIsmael Ghanem
Ismael Ghanem
MMManuel González Moya
Manuel González Moya
CCCaterina Calderon
Caterina Calderon
This study examines the mediating role of social support between anxious preoccupation and resilience in patients with cancer during COVID-19. NEOetic_SEOM is a prospective, multicenter study involving individuals with advanced, unresectable cancer who completed the following scales: Resilience (BCRS), Social Support (Duke-UNC-11), and anxious preoccupation subscale of the Mini-Mental Adjustment to Cancer (M-MAC) before starting antineoplastic treatment. Between March 2020 and July 2021, 507 patients (55% male; mean age, 65) were recruited. No differences in resilience were observed based on sociodemographic or clinical characteristics. Social support in people with advanced, unresectable cancer promotes both decreased anxious preoccupation and greater resilience.